These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26482315)

  • 21. Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.
    Vallabhaneni S; Almendares O; Farley MM; Reno J; Smith ZT; Stein B; Magill SS; Smith RM; Cleveland AA; Lessa FC
    Epidemiol Infect; 2016 May; 144(7):1440-4. PubMed ID: 26608090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population?
    von Baum H; Ober JF; Wendt C; Wenzel RP; Edmond MB
    Infection; 2005 Oct; 33(5-6):320-6. PubMed ID: 16258861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
    Abutaleb NS; Seleem MN
    Sci Rep; 2020 May; 10(1):7701. PubMed ID: 32382070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
    Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
    Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
    Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
    Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.
    Yoon YK; Kim MJ; Sohn JW; Kim HS; Choi YJ; Kim JS; Kim ST; Park KH; Kim SJ; Kim BS; Shin SW; Kim YH; Park Y
    Support Care Cancer; 2014 Aug; 22(8):2039-48. PubMed ID: 24595407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enteropathogenetic nosocomial infections: predisposing clinical characteristics and risk of recurrent infections.
    Corcione S; Segala FV; Castiglione A; Lupia T; Angilletta R; Cavallo R; Ciccone G; De Rosa FG
    J Chemother; 2019; 31(7-8):394-400. PubMed ID: 31556352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
    Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
    Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing epidemiology of Clostridium difficile infections.
    Freeman J; Bauer MP; Baines SD; Corver J; Fawley WN; Goorhuis B; Kuijper EJ; Wilcox MH
    Clin Microbiol Rev; 2010 Jul; 23(3):529-49. PubMed ID: 20610822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
    Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of ribotype 027 on Clostridium difficile infection in a geriatric department.
    Mascart G; Delmée M; Van Broeck J; Cytryn E; Karmali R; Cherifi S
    Eur J Clin Microbiol Infect Dis; 2013 Sep; 32(9):1177-82. PubMed ID: 23558363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections.
    Ikeda M; Yagihara Y; Tatsuno K; Okazaki M; Okugawa S; Moriya K
    Ann Clin Microbiol Antimicrob; 2015 Sep; 14():43. PubMed ID: 26370137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.